Dupilumab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Alopecia Areata. According to GlobalData, Phase II drugs for Alopecia Areata have a 48% phase ...

Do not use if you are allergic to dupilumab or to any of the ingredients ... with platinum-containing chemotherapy include hair loss, muscle or bone pain, nausea, tiredness, numbness, pain ...

The GWAS summary data for smoking, alcohol consumption, obesity and autoimmune diseases (alopecia areata, vitiligo ... such as baricitinib (JAK1/2 inhibitor) and dupilumab (anti-IL-4Rα), which have ...

Two years ago, Sanofi and Regeneron broke new ground by getting their Dupixent (dupilumab ... androgenic alopecia, and fungal nail infections. “The Dermira deal has been a very important ...

Do not use if you are allergic to dupilumab or to any of the ingredients in DUPIXENT ... when used in combination with platinum-containing chemotherapy include hair loss, muscle or bone pain, nausea, ...

Sanofi is already a major player in the ASD market with its big-selling IL-4 and IL-13 inhibitor Dupixent (dupilumab), and the company has previously highlighted amlitelimab as one of a dozen ...

Alopecia areata (AA) is a common non-scarring hair loss condition ... antibodies targeting the type 2 inflammatory pathway (dupilumab), and Janus kinase (JAK) inhibitors (baricitinib, abrocitinib, ...

Dupilumab is under clinical development by Regeneron Pharmaceuticals ... dermatitis (eczema), chronic obstructive pulmonary disease (COPD), chronic bronchitis, alopecia areata, bullous pemphigoid, ...

Alopecia areata is a chronic autoimmune disorder causing non-scarring hair loss due to immune system attacks on hair follicles. Breakdown of immune privilege in hair follicles leads to ...

Wayde Cadogan bares all on TikTok as she turns her alopecia diagnosis into a platform for awareness, self-acceptance and a redefining of beauty standards Ashley Vega is a writer-reporter at PEOPLE.

Alopecia areata is a chronic autoimmune disorder causing non-scarring hair loss due to immune system attacks on hair follicles. Breakdown of immune privilege in hair follicles leads to ...